التفاصيل البيبلوغرافية
| العنوان: |
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials |
| المؤلفون: |
Cremolini, C., Loupakis, F., Masi, G., Lonardi, S., Granetto, C., Mancini, M.L., Chiara, S., Moretto, R., Rossini, D., Vitello, S., Allegrini, G., Tonini, G., Bergamo, F., Tomasello, G., Ronzoni, M., Buonadonna, A., Bustreo, S., Barbara, C., Boni, L., Falcone, A. * |
| المصدر: |
In Annals of Oncology May 2016 27(5):843-849 |
| قاعدة البيانات: |
ScienceDirect |
